{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:41:48Z","timestamp":1773150108768,"version":"3.50.1"},"reference-count":43,"publisher":"Frontiers Media SA","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1121,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1111\/j.1432-2277.2012.01520.x","type":"journal-article","created":{"date-parts":[[2012,8,6]],"date-time":"2012-08-06T14:38:21Z","timestamp":1344263901000},"page":"941-947","source":"Crossref","is-referenced-by-count":8,"title":["Liver-kidney recipients with chronic viral hepatitis C treated with interferon-alpha"],"prefix":"10.3389","volume":"25","author":[{"given":"Qussai","family":"Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Roche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Buffet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Bessede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Charpentier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Durrbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2012,8,6]]},"reference":[{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3748\/wjg.v18.i1.55","article-title":"Efficacy and safety of treatment of hepatitis C virus infection in renal transplant recipients","volume":"18","author":"Aljumah","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1034\/j.1600-6143.2003.30113.x","article-title":"Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy","volume":"3","author":"Baid","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00007890-199311000-00009","article-title":"Chronic hepatitis C after renal transplantation: treatment with alpha-interferon","volume":"56","author":"Chan","year":"1993","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB4|cit4","first-page":"S135","article-title":"Long-term results of treatment of chronic hepatitis B, C and D with interferon-alpha in renal allograft recipients","volume":"11","author":"Durlik","year":"1998","journal-title":"Transpl Int"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0140-6736(84)92327-4","article-title":"Recombinant leucocyte interferon A induces steroid-resistant acute vascular rejection episodes in renal transplant recipients","volume":"1","author":"Kramer","year":"1984","journal-title":"Lancet"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1097\/00007890-199504150-00030","article-title":"Interferon-alpha-induced acute renal allograft rejection","volume":"59","author":"Magnone","year":"1995","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB7|cit7","first-page":"2104","article-title":"Recombinant alpha-interferon in renal allograft recipients with chronic hepatitis C","volume":"10","author":"Ozgur","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1097\/00007890-199505270-00012","article-title":"Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients","volume":"59","author":"Rostaing","year":"1995","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1159\/000189444","article-title":"Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis C","volume":"74","author":"Rostaing","year":"1996","journal-title":"Nephron"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00007890-199409150-00018","article-title":"Low-dose recombinant leukocyte interferon-alpha treatment of hepatitis C viral infection in renal transplant recipients: a pilot study","volume":"58","author":"Thervet","year":"1994","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/hep.510260236","article-title":"Pilot study of the combination of interferon alpha and ribavirin as therapy of recurrent hepatitis C after liver transplantation","volume":"26","author":"Bizollon","year":"1997","journal-title":"Hepatology"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/S0041-1345(98)00554-5","article-title":"Treatment of recurrent hepatitis C virus infection after liver transplantation with interferon and ribavirin","volume":"30","author":"Gotz","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0041-1345(96)00248-5","article-title":"Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin combination","volume":"29","author":"Mazzaferro","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/hep.510280334","article-title":"The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation","volume":"28","author":"Sheiner","year":"1998","journal-title":"Hepatology"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1034\/j.1600-6143.2003.00050.x","article-title":"Incidence of renal and liver rejection and patient survival rate following combined liver and kidney transplantation","volume":"3","author":"Creput","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/00007890-199605150-00021","article-title":"The liver neither protects the kidney from rejection nor improves kidney graft survival after combined liver and kidney transplantation from the same donor","volume":"61","author":"Katznelson","year":"1996","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1053\/gast.2002.33023","article-title":"Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C","volume":"122","author":"Poynard","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1017\/S0266462305050075","article-title":"Effectiveness and cost-effectiveness of initial combination therapy with interferon\/peginterferon plus ribavirin in patients with chronic hepatitis C in Germany: a health technology assessment commissioned by the German Federal Ministry of Health and Social Security","volume":"21","author":"Siebert","year":"2005","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/gut.52.3.425","article-title":"Cost effectiveness of peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C","volume":"52","author":"Siebert","year":"2003","journal-title":"Gut"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/j.1572-0241.2004.30286.x","article-title":"Cost-effectiveness of combination peginterferon alpha-2a and ribavirin compared with interferon alpha-2b and ribavirin in patients with chronic hepatitis C","volume":"99","author":"Sullivan","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jhep.2003.12.015","article-title":"Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination","volume":"40","author":"Dumortier","year":"2004","journal-title":"J Hepatol"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/01.mcg.0000225569.04773.8b","article-title":"Treatment with pegylated interferon and ribavirin for hepatitis C virus-associated severe cryoglobulinemia in a liver\/kidney transplant recipient","volume":"41","author":"Montalbano","year":"2007","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jhep.2009.05.025","article-title":"Outcomes of patients with hepatitis C undergoing simultaneous liver-kidney transplantation","volume":"51","author":"Van Wagner","year":"2009","journal-title":"J Hepatol"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.transproceed.2011.01.001","article-title":"Treatment of hepatitis C virus infection in kidney transplant recipients: case report","volume":"43","author":"Caeiro","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1097\/00007890-199811150-00023","article-title":"Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy","volume":"66","author":"Toth","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB27|cit27","first-page":"739","article-title":"Increased expression of human monocyte HLA-DR antigens and Fc gamma receptors in response to human interferon in vivo","volume":"53","author":"Rhodes","year":"1983","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0272-6386(03)00422-0","article-title":"Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology","volume":"42","author":"Kamar","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/01.TP.0000128911.87538.AA","article-title":"Histopathologic efficacy of ribavirin monotherapy in kidney allograft recipients with chronic hepatitis C","volume":"78","author":"Fontaine","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1097\/01.TP.0000158279.29506.E0","article-title":"Lack of evidence for ribavirin monotherapy efficacy on liver fibrosis in hepatitis C virus positive renal transplant patients","volume":"79","author":"Kamar","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/00007890-200211270-00008","article-title":"Prolongation of long-term kidney graft survival by a simultaneous liver transplant: the liver does it, and the heart does it too","volume":"74","author":"Opelz","year":"2002","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.trim.2006.11.007","article-title":"New aspect of immunosuppressive treatment in liver transplantation. How could you induce tolerance in liver transplantation?","volume":"17","author":"Beaudreuil","year":"2007","journal-title":"Transpl Immunol"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/00007890-199010000-00029","article-title":"Specific suppression of allograft rejection by soluble class I antigen and complexes with monoclonal antibody","volume":"50","author":"Sumimoto","year":"1990","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1053\/jhep.2000.9124","article-title":"Liver from bone marrow in humans","volume":"32","author":"Theise","year":"2000","journal-title":"Hepatology"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1084\/jem.193.11.1311","article-title":"CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade","volume":"193","author":"Taylor","year":"2001","journal-title":"J Exp Med"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0168-8278(03)00354-4","article-title":"Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation","volume":"39","author":"Creput","year":"2003","journal-title":"J Hepatol"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.humimm.2003.08.356","article-title":"Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver-kidney transplantation: possible implications for monitoring patients","volume":"64","author":"Creput","year":"2003","journal-title":"Hum Immunol"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1111\/j.1600-6143.2009.02743.x","article-title":"Increased expression of regulatory Tr1 cells in recurrent hepatitis C after liver transplantation","volume":"9","author":"Carpentier","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1097\/01.tp.0000258729.68871.be","article-title":"Elevated interleukin-4 expression in severe recurrent hepatitis C virus after liver transplantation","volume":"83","author":"Dharancy","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s000180050295","article-title":"Immunotolerant functions of HLA-G","volume":"55","author":"Carosella","year":"1999","journal-title":"Cell Mol Life Sci"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0167-5699(98)01387-5","article-title":"HLA-G: a tolerance molecule from the major histocompatibility complex","volume":"20","author":"Carosella","year":"1999","journal-title":"Immunol Today"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1006\/scbi.1998.0103","article-title":"The immunotolerance role of HLA-G","volume":"9","author":"Rouas-Freiss","year":"1999","journal-title":"Semin Cancer Biol"},{"key":"10.1111\/j.1432-2277.2012.01520.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.transproceed.2011.02.033","article-title":"Combined liver kidney transplantation: critical analysis of a single-center experience","volume":"43","author":"Cimsit","year":"2011","journal-title":"Transplant Proc"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1432-2277.2012.01520.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1432-2277.2012.01520.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T18:35:55Z","timestamp":1641062155000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1432-2277.2012.01520.x"}},"subtitle":["IFN-alpha and liver-kidney recipients"],"short-title":[],"issued":{"date-parts":[[2012,8,6]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1432-2277.2012.01520.x","relation":{},"ISSN":["0934-0874"],"issn-type":[{"value":"0934-0874","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8,6]]}}}